- Recent Funding
- Investors
- Casdin Capital
Casdin Capital portfolio
Casdin Capital has 15 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.
About this page
It is a venture capital firm based in New York, US, founded in 2012. It led 2 of the 15 rounds it joined. Its most recent investment on record is City Therapeutics's $99.5M Series B+ round in June 2026, alongside Viking Global Investors, Slate Path Capital, ARCH Venture Partners and 6 others. By category, its portfolio leans toward Health and bio (15) and Logistics and mobility (2). It has co-invested with Nextech Invest, ARCH Venture Partners and Rock Springs Capital, most often Nextech Invest (6 rounds).
About Casdin Capital
What Casdin Capital invests in
- Health and bio · 15 · 100%
- Logistics and mobility · 2 · 13%
- Data and analytics · 2 · 13%
- Education · 1 · 7%
Casdin Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $99.5M | Viking Global Investors (lead), Slate Path Capital, ARCH Venture Partners +6 | ||
| Series B+ · $80M | OpAmp Capital, Operator Partners, Upside Partnership +5 | ||
| Series A · $200M | AI Life Sciences Investments LLC (lead), ARCH Venture Partners, Fidelity +7 | ||
| Series B+ · $120M | Forge Life Science Partners, Merck KGaA, Darmstadt, Germany, Commodore Capital (lead) +6 | ||
| Series A · $270M | Moore Strategic Ventures, ARCH Venture Partners (lead), Redmile Group +6 | ||
| Series A · $122M · lead | Forge Life Science Partners, Andreessen Horowitz (lead), Nextech Invest | ||
| Series A · $18M | Lifeforce Capital, Cantos, Catalio +6 | ||
| Series B+ · $75M · lead | ARCH Venture Partners (lead), ARTIS Ventures, Vertical Venture Partners +3 |
How Casdin Capital invests
Casdin Capital portfolio companies
CCity Therapeutics$99.5MSeries B+ · Jun 2026
AApella Technology$80MSeries B+ · Jan 2026
TTreeline Biosciences$200MSeries A · Sep 2025
IIDRx$120MSeries B+ · Aug 2024
OOrbital Therapeutics$270MSeries A · Apr 2023
CCharacter Bio$18MSeries A · May 2022
OONI$75MSeries B+ · Jan 2022
VVerana Health$150MSeries B+ · Jan 2022
NNomic Bio$17MSeries A · Dec 2021
EExo Therapeutics$78MSeries B+ · Oct 2021
TT-Knife$110MSeries B+ · Aug 2021
FFlare Therapeutics$82MSeries A · May 2021
AA2 Biotherapeutics$71.5MSeries B+ · Oct 2020
MMOMA Therapeutics$86MSeries A · Apr 2020
TTriGemX Biobacker
| Company | Round with Casdin Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $99.5M | $234.5M | Aug 8, 2026 Series B+ |
Health and bio |
Series B+ · $80M | $80M | Jan 8, 2026 Series B+ |
Health and bio |
Series A · $200M | $461M | Sep 3, 2025 Series A |
Health and bio |
Series B+ · $120M | $242M | Aug 8, 2024 Series B+ |
Health and bio |
Series A · $270M | $270M | Aug 3, 2025 Series A |
Health and bio |
Series A · $18M | $111M | Mar 25, 2025 Series B+ |
Health and bio |
Series B+ · $75M · lead | $75M | Jan 29, 2022 Series B+ |
Health and bio |
Series B+ · $150M | $202M | Apr 30, 2026 Series B+ |
Health and bio |
Series A · $17M | $59M | Sep 17, 2024 Series B+ |
Health and bio |
Series B+ · $78M | $103M | Oct 5, 2021 Series B+ |
Health and bio |
Series B+ · $110M | $188M | Aug 2, 2021 Series B+ |
Health and bio |
Series A · $82M | $167M | Jun 30, 2026 Series B+ |
Health and bio |
Series B+ · $71.5M | $270.5M | Jan 10, 2025 Series B+ |
Health and bio |
Series A · $86M | $236M | May 10, 2022 Series B+ |
Health and bio |
backer | $94M | Oct 1, 2026 round |
Most frequent co-investors
NNextech Invest6 shared rounds · last Aug 8, 2024
AARCH Venture Partners4 shared rounds · last Jun 8, 2026
RRock Springs Capital4 shared rounds · last Jun 8, 2026
IInvus3 shared rounds · last Jun 8, 2026
FFidelity3 shared rounds · last Jun 8, 2026
GGV2 shared rounds · last Sep 3, 2025
AAndreessen Horowitz2 shared rounds · last Aug 8, 2024
RRA Capital Management2 shared rounds · last Aug 8, 2024
FForge Life Science Partners2 shared rounds · last Aug 8, 2024
NNewpath Management2 shared rounds · last Apr 26, 2023
SS322 shared rounds · last May 17, 2022
SSamsara Biocapital2 shared rounds · last Oct 5, 2021
Similar investors
QQiming Venture Partners15 companies · 6 deals in 12 mo
MMayo Clinic15 companies · 4 deals in 12 mo
CCormorant Asset Management16 companies · 4 deals in 12 mo
MMaverick Ventures16 companies · 4 deals in 12 moBBling Capital16 companies · 3 deals in 12 mo
FForesite Capital16 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 15 rounds on Recent Funding that name Casdin Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Casdin Capital, which is a subset of its real portfolio. API: /api/v1/investors/casdin-capital (get a free API key). More: the most active VC firms and new venture capital funds.